0.9842
price down icon2.07%   -0.0208
 
loading
前日終値:
$1.005
開ける:
$0.9683
24時間の取引高:
180.21K
Relative Volume:
1.11
時価総額:
$64.84M
収益:
-
当期純損益:
$-86.08M
株価収益率:
-0.4562
EPS:
-2.1574
ネットキャッシュフロー:
$-72.06M
1週間 パフォーマンス:
-15.16%
1か月 パフォーマンス:
+7.65%
6か月 パフォーマンス:
-14.42%
1年 パフォーマンス:
-39.99%
1日の値動き範囲:
Value
$0.927
$1.01
1週間の範囲:
Value
$0.9269
$1.1986
52週間の値動き範囲:
Value
$0.66
$1.79

Io Biotech Inc Stock (IOBT) Company Profile

Name
名前
Io Biotech Inc
Name
セクター
Healthcare (1162)
Name
電話
(457) 070-2980
Name
住所
OLE MAALOES VEH 3, COPENHAGEN
Name
職員
80
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
IOBT's Discussions on Twitter

IOBT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IOBT
Io Biotech Inc
0.9842 64.84M 0 -86.08M -72.06M -2.1574
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Io Biotech Inc (IOBT) 最新ニュース

pulisher
Apr 02, 2025

Top 5 AI & Digital Biotech Companies (April 2025) - Securities.io

Apr 02, 2025
pulisher
Apr 02, 2025

IO Biotech (NASDAQ:IOBT) Given “Buy” Rating at HC Wainwright - Defense World

Apr 02, 2025
pulisher
Mar 27, 2025

IO Biotech secures over 400 million dkk in new capital - Dansk Industri

Mar 27, 2025
pulisher
Mar 25, 2025

IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

IO Biotech Announces Acceptance Of Abstracts To Be Presented At The 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Cancer Vaccine Breakthrough: IO Biotech Reveals Phase 3 Melanoma Data at AACR 2025 - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 21, 2025

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail

Mar 21, 2025
pulisher
Mar 20, 2025

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 20, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company’s World’s Most Innovative Companies of 2025 - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Fast Company Names IO Biotech Top 10 Innovator for Cancer Vaccine Breakthrough - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025
pulisher
Mar 17, 2025

Partex and Fortress Biotech Announce Strategic - GlobeNewswire

Mar 17, 2025
pulisher
Mar 15, 2025

IO Biotech (NASDAQ:IOBT) Upgraded at Piper Sandler - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

Cancer Vaccines Market Analysis: Growth Drivers - openPR.com

Mar 13, 2025
pulisher
Mar 12, 2025

Bavarian Nordic A/S – Notice Convening Annual General Meeting - Finansavisen

Mar 12, 2025
pulisher
Mar 07, 2025

HC Wainwright Reiterates “Buy” Rating for IO Biotech (NASDAQ:IOBT) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Mar 06, 2025
pulisher
Mar 05, 2025

Ratio Chart Of U.S. Dollar Index Against 10Y U.S. Notes Is Pointing Much Lower - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Melanoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Melanoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

BJ's (BJ) Q4 Earnings: What To Expect - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Dollar Retreats on Growth Risk From US Tariffs - The Globe and Mail

Mar 05, 2025
pulisher
Mar 05, 2025

Metastatic Melanoma Pipeline 2024: Key Companies, MOA, ROA, - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

IOBT To Report Melanoma Trial Data In Q3, NPCE Eyes 15-20% Revenue Growth For 2025, DXR On Watch - RTTNews

Mar 05, 2025
pulisher
Mar 05, 2025

IO Biotech on track with cancer vaccine BLA for 2025 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 04, 2025

IO Biotech on track with cancer vaccine BLA for 2025 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

IO Biotech Reports 2024 Business Highlights - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

IO Biotech Reports Progress on Cylembio® Development and Upcoming FDA Submission Plans - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Cancer Vaccine Breakthrough? IO Biotech Accelerates Path to FDA Approval with Early Trial Completion - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

The Search for the Next Keytruda: Immuno-Oncology’s Next Play - BioSpace

Mar 03, 2025
pulisher
Mar 02, 2025

5 Best Biotech Stocks To Watch (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 02, 2025

IO Biotech (IOBT) to Release Quarterly Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

United States Steel: Buy, Sell, or Hold? - The Globe and Mail

Mar 01, 2025
pulisher
Feb 28, 2025

Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews

Feb 28, 2025
pulisher
Feb 26, 2025

Metastatic Melanoma Clinical Trials and Pipeline 2025: EMA, - openPR

Feb 26, 2025
pulisher
Feb 24, 2025

Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews

Feb 24, 2025
pulisher
Feb 24, 2025

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewswire

Feb 24, 2025
pulisher
Feb 23, 2025

Artivion (AORT) Q4 Earnings: What To Expect - The Globe and Mail

Feb 23, 2025
pulisher
Feb 23, 2025

Should You Buy IonQ Stock Before Feb. 26? - The Globe and Mail

Feb 23, 2025
pulisher
Feb 23, 2025

IO Biotech Announces Positive Findings on TGF-β-Directed Peptide Vaccine for Solid Tumors at AACR-IO Conference - Nasdaq

Feb 23, 2025
pulisher
Feb 23, 2025

Can This New Cancer Vaccine Outsmart Tumors? IO Biotech's Breakthrough Approach - StockTitan

Feb 23, 2025
pulisher
Feb 23, 2025

32,667 Shares in IO Biotech, Inc. (NASDAQ:IOBT) Purchased by Vontobel Holding Ltd. - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

3 Reasons to Avoid SGH and 1 Stock to Buy Instead - The Globe and Mail

Feb 21, 2025
pulisher
Feb 20, 2025

IO Biotech to Present at the 45th Annual Cowen Health Care Conference - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Can IO Biotech's Cancer Vaccine Pipeline Transform Immunotherapy? CEO Reveals Latest Progress - Stock Titan

Feb 20, 2025
pulisher
Feb 19, 2025

IO Biotech (NASDAQ:IOBT) Trading Up 4.2%Here's What Happened - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Head and Neck Squamous Cell Carcinoma Market Analysis 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Treatment Market, NDA Approval, Epidemiology and Companies by DelveInsight - Barchart

Feb 19, 2025

Io Biotech Inc (IOBT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):